A phase III, Multi Centre, Randomised, Double- Blind, Placebo-Controlled Study of Marimastat in Patients with Ovarian Cancer following a complete or partial response to Second-Line Chemotherapy

  • Poole, Christopher (Principal Investigator)

Project Details

Short titleA phase III, Multi Centre, Randomised, Double- Blind, Placebo-Controlled Study of Marimastat in Patients with Ovarian Cancer following a complete or partial response to Second-Line Chemotherapy
StatusFinished
Effective start/end date1/04/98 → 31/07/00

Funding

  • BRITISH BIOTECH PHARMACEUTICALS LTD